The potential mechanism of N-acetylcysteine in treating COVID-19

N Zhou, X Yang, A Huang… - Current pharmaceutical …, 2021 - ingentaconnect.com
N-Acetylcysteine (NAC) has been proposed to be used to treat Coronavirus Disease 2019
(COVID-19). By reviewing the existing pathological studies of COVID-19, it was found that …

Perspectives for the use of N-acetylcysteine as a candidate drug to treat COVID-19

P Luo, Y Liu, D Liu, J Li - Mini reviews in medicinal chemistry, 2021 - ingentaconnect.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndromerelated coronavirus-2 (SARS-CoV-2), has become an ongoing pandemic …

N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2

FL Poe, J Corn - Medical hypotheses, 2020 - Elsevier
COVID-19, a respiratory disease caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2), continues to spread across the globe. Predisposing factors such as age …

[HTML][HTML] N-acetylcysteine and coronavirus disease 2019: May it work as a beneficial preventive and adjuvant therapy? A comprehensive review study

N Atefi, E Behrangi, S Mozafarpoor… - Journal of Research …, 2020 - journals.lww.com
Background: Coronaviruses are major pathogens of respiratory system causing different
disorders, including the common cold, Middle East respiratory syndrome, and severe acute …

[HTML][HTML] Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19

A Dominari, D Hathaway III, A Kapasi… - World Journal of …, 2021 - ncbi.nlm.nih.gov
N-acetylcysteine (NAC) is an abundantly available antioxidant with a wide range of antidotal
properties currently best studied for its use in treating acetaminophen overdose. It has a …

[HTML][HTML] N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions

JL Izquierdo-Alonso, S Pérez-Rial, CG Rivera… - Journal of infection and …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes
coronavirus disease 2019 (COVID-19) and can be associated with serious complications …

N-acetylcysteine to combat COVID-19: an evidence review

Z Shi, CA Puyo - Therapeutics and clinical risk management, 2020 - Taylor & Francis
The novel coronavirus disease (COVID-19) is caused by a virus (SARS-Cov-2) and is known
for inducing multisystem organ dysfunction associated with significant morbidity and …

[HTML][HTML] Is N-acetylcysteine effective in treating patients with coronavirus disease 2019? A meta-analysis

CH Chen, KF Hung, CY Huang, JL Leong… - Journal of the …, 2023 - journals.lww.com
Background: Coronavirus disease 2019 (COVID-19) is a global pandemic caused by severe
acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). It has brought tremendous …

N-acetylcysteine as adjuvant therapy for COVID-19–a perspective on the current state of the evidence

KK Wong, SWH Lee, KP Kua - Journal of inflammation research, 2021 - Taylor & Francis
The looming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
long-lasting pandemic of coronavirus disease 2019 (COVID-19) around the globe with …

Where are we with the use of N-acetylcysteine as a preventive and adjuvant treatment for COVID-19?

F Di Marco, G Foti, AG Corsico - European Review for Medical and …, 2022 - air.unimi.it
OBJECTIVE: As N-acetylcysteine (NAC) is promising as a re-purposed drug for the
adjunctive or supportive treatment of serious COVID-19, this article aimed to describe …